Media Top News In The News Media Resources TOP NEWS November 05, 2026Biohaven Drives New Research in Graves' Disease: Phase 3 Pivotal Trial with BHV-1300 Underway and Three Scientific Posters at the 2026 American Thyroid Association Annual (ATA) Meeting October 29, 2026Biohaven Reports Recent Business Developments and Third Quarter 2026 Financial Results October 26, 2026Biohaven Oral Presentation at ASN Kidney Week 2026 Spotlights BHV-1420, a Novel TRAP Degrader Designed to Selectively Remove the Autoantibodies that Drive Membranous Nephropathy VIEW ALL WE ARE SOCIAL